Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Announces Signing of Definitive Agreement to Acquire Drug Lab 118 (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News AstraZeneca ADR Representing 0.5 Ord Shs AZN

Consumer Cyclical Healthcare Advertising Agencies
AstraZeneca PLC is a science-led biopharmaceutical company. It discovers, develops, and commercializes prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolism, respiratory and immunology and vaccines and immune therapies. Its key marketed oncology products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Zoladex... see more

Recent & Breaking News (NDAQ:AZN)

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AstraZeneca PLC and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA February 1, 2021

AZN Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Notifies AstraZeneca PLC Shareholders of Class Action and Encourages Shareholders to Contact the Firm

ACCESSWIRE IA February 1, 2021

BREAKING ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors with Large Losses to Secure Counsel Before Important Deadline - AZN

GlobeNewswire January 31, 2021

AstraZeneca Shareholder Alert

Newsfile January 31, 2021

BREAKING NOTICE: ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors with Large Losses to Secure Counsel Before Important Deadline - AZN

PR Newswire January 29, 2021

Investor Alert: Kaplan Fox Investigates Potential Securities Fraud At AstraZeneca PLC

PR Newswire January 29, 2021

AstraZeneca Deadline Alert

Newsfile January 29, 2021

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of AstraZeneca PLC (AZN) Investors

Business Wire January 29, 2021

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AstraZeneca PLC and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

PR Newswire January 29, 2021

TAGRISSO Extended Disease-Free Survival Regardless of Prior Adjuvant Chemotherapy in Early-Stage EGFR-Mutated Lung Cancer

Business Wire January 29, 2021

SHAREHOLDER ALERT: Lowey Dannenberg, P.C. Announces Filing of Securities Class Action Lawsuit Against AstraZeneca plc on Behalf of Investors Who Acquired Shares from May 21, 2020 to November 20, 2020 and Encourages Investors to Inquire About the Lead Plaintiff Position Before the March 29, 2021 Lead Plaintiff Deadline

GlobeNewswire January 28, 2021

IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AstraZeneca PLC and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA January 28, 2021

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AstraZeneca PLC and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

ACCESSWIRE IA January 28, 2021

AstraZeneca Investor Alert: Class Action Lawsuit Filed

Newsfile January 28, 2021

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AstraZeneca PLC and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Business Wire January 28, 2021

Portnoy Law: Lawsuit Filed On Behalf of AstraZeneca PLC Investors

GlobeNewswire January 28, 2021

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Invites AstraZeneca (AZN) Investors to Contact Firm, Securities Fraud Case Related to Potential COVID-19 Treatment Filed

PR Newswire January 28, 2021

AZN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 29, 2021 in the Class Action Filed on Behalf of Astrazeneca Plc Limited Shareholders

Newsfile January 27, 2021

ASTRAZENECA ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against AstraZeneca PLC and Encourages Investors to Contact the Firm

Business Wire January 27, 2021

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of AstraZeneca PLC (AZN) on Behalf of Investors

Business Wire January 27, 2021